Skip to main content

Table 2 Baseline cardiac history & HRQoL characteristics between CR participants and non-Participants

From: Cardiac rehabilitation may not provide a quality of life benefit in coronary artery disease patients

 

n

No CR (n = 153)

n

CR (n = 68)

Pre-Angiography Cardioprotective Therapy

Anti-platelet

153

84%

68

82%

Beta-blockers

153

35%

68

19%

Statins

153

67%

68

66%

ACE-inhibitor

153

42%

68

40%

Angiotensin Receptor Blocker

153

18%

68

13%

Obstructive CAD Findings

Single Vessel Disease

153

29%

68

32%

Double Vessel Disease

 

39%

 

32%

Triple Vessel Disease

 

32%

 

35%

Initial Treatment Strategy

Medical Therapy

153

56%

68

41%

Coronary Angioplasty/stent

 

30%

 

43%

Coronary bypass graft

 

14%

 

16%

Seattle Angina Questionnaire

Physical Limitation

153

54±25

68

64±22*

Angina Stability

153

37±31

68

40±34

Angina Frequency

153

59±27

68

66±27

Treatment Satisfaction

153

90±16

68

89±18

Quality of Life

153

42±22

68

44±24

Short-Form 36

Physical Summary Score

153

34±11

68

38±11

Mental Summary Score

153

42±11

68

43±11

Elevated Psychosocial Distress

153

62%

68

47%*

  1. *p < 0.05, **p < 0.01, age adjusted.